EnergyPathways PLC Exercise of Warrants

RNS Number : 4818N

EnergyPathways PLC

25 November 2024

 

25 November 2024

EnergyPathways plc

 

("EnergyPathways" or the "Company")

 

Exercise of Warrants

 

EnergyPathways plc (AIM: EPP), an integrated energy transition company, announces that on[22 November 2024, it received notices to exercise 1,000,000 warrants over new ordinary shares in the Company ("Warrant Shares") at 5p per ordinary share, raising a total of £50,000 for the Company.

 

Admission and Total Voting Rights

Application will be made for the Warrant Shares to be admitted to trading on AIM, which is expected to occur on or around 28 November 2024 ("Admission"). The Warrant Shares will rank pari passu in all respects with the Company's existing ordinary shares currently traded on AIM.

Following Admission, the Company's issued share capital will comprise 167,045,345 ordinary shares of 1 pence each. This number will represent the total voting rights in the Company and may be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

Enquiries:

 

EnergyPathways interactive investor website Sign up to the hub to receive news and engage with the management team energypathways.uk EnergyPathways Ben Clube / Ben Hodges Tel: [phone], c/o Buchanan (Financial PR) Cairn Financial Advisers LLP (Nominated Adviser) Jo Turner / Louise O'Driscoll / Sandy Jamieson Tel: [phone] SP Angel Corporate Finance LLP (Broker) Richard Hail / Adam Cowl Tel: [phone] Buchanan (Financial PR) Ben Romney / Barry Archer Tel: [phone] Email: [e-mail]

 

For further information on EnergyPathways visit www.energypathways.uk and @energy_pathways on X (formerly Twitter).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

IOEPPGBAGUPCGQC